About 9,250 results
Open links in new tab
  1. The New England Journal of Medicine | Research & Review Articles …

    6 days ago · The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide …

  2. Current Issue | New England Journal of Medicine

    Explore the current issue of The New England Journal of Medicine (Vol. 393 No. 18).

  3. Antibiotic Treatment for 7 versus 14 Days in Patients with …

    Nov 20, 2024 · Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In …

  4. Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

    Dec 11, 2024 · In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer that recurred or …

  5. Lepodisiran - The New England Journal of Medicine

    Mar 30, 2025 · Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small …

  6. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

    Jun 1, 2025 · In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a …

  7. Tirzepatide for Heart Failure with Preserved Ejection Fraction and ...

    Nov 16, 2024 · Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and …

  8. Tarlatamab in Small-Cell Lung Cancer after Platinum-Based …

    Jun 2, 2025 · Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell …

  9. Remibrutinib in Chronic Spontaneous Urticaria | New England …

    Mar 5, 2025 · Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of these symptoms) for more than 6 weeks. …

  10. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

    Apr 23, 2025 · In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl …